The cold and flu viruses that many have avoided while staying at home and social distancing during the COVID-19 pandemic will likely run rampant again as masks come off and schools reopen, reports STAT News.
Category: Flu & Respiratory Infections
The system was specifically developed to enable decentralized sample processing, while the resulting data can be stored and analyzed centrally anywhere in the world.Read More
Over time, the American Medical Association has established specific current procedural terminology codes to be used in reporting the results of testing by means of such multiplex molecular pathology panels.Read More
While viral culture is very sensitive, its long turnaround time, high cost, and requisite skill have made the method obsolete in most laboratories throughout the United States.Read More
The Cobas Liat test is the first CLIA-waived real-time polymerase chain reaction test to detect influenza A and B in approximately 20 minutes.Read More
FDA has granted a Clinical Laboratory Improvement Amendments waiver to the Alere i Influenza A & B test, the only molecular test to detect and differentiate influenza A and B virus in less than 15 minutes, and now the first molecular test to receive a CLIA waiver.Read More